ATE401065T1 - Orale zubereitungen, die wirtsantwortmodulierenden wirkstoffe enthalten - Google Patents

Orale zubereitungen, die wirtsantwortmodulierenden wirkstoffe enthalten

Info

Publication number
ATE401065T1
ATE401065T1 AT01950569T AT01950569T ATE401065T1 AT E401065 T1 ATE401065 T1 AT E401065T1 AT 01950569 T AT01950569 T AT 01950569T AT 01950569 T AT01950569 T AT 01950569T AT E401065 T1 ATE401065 T1 AT E401065T1
Authority
AT
Austria
Prior art keywords
agents
oral
present
host
oral cavity
Prior art date
Application number
AT01950569T
Other languages
English (en)
Inventor
Matthew Doyle
Stephen Hunter-Rinderle
Robert Singer
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24432968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE401065(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE401065T1 publication Critical patent/ATE401065T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Finger-Pressure Massage (AREA)
AT01950569T 2000-06-30 2001-06-28 Orale zubereitungen, die wirtsantwortmodulierenden wirkstoffe enthalten ATE401065T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60760200A 2000-06-30 2000-06-30

Publications (1)

Publication Number Publication Date
ATE401065T1 true ATE401065T1 (de) 2008-08-15

Family

ID=24432968

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01950569T ATE401065T1 (de) 2000-06-30 2001-06-28 Orale zubereitungen, die wirtsantwortmodulierenden wirkstoffe enthalten

Country Status (12)

Country Link
US (1) US8277782B2 (de)
EP (1) EP1294367B1 (de)
JP (1) JP4754155B2 (de)
CN (1) CN1536989A (de)
AT (1) ATE401065T1 (de)
AU (1) AU2001271544A1 (de)
CA (1) CA2415065C (de)
DE (1) DE60134854D1 (de)
ES (1) ES2309076T3 (de)
MX (1) MXPA03000043A (de)
PE (1) PE20020102A1 (de)
WO (1) WO2002002096A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
US20040101494A1 (en) 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
WO2005025527A1 (de) 2003-09-09 2005-03-24 Dsm Ip Assets B.V. Oral wirkendes im wesentlichen wasserfreies topisches mittel enthaltend ein oder mehrere oxidationsempfindliche stoffe
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
AU2004289248B2 (en) 2003-11-07 2012-05-03 U.S. Smokeless Tobacco Company Llc Tobacco compositions
CN109134205B (zh) 2004-05-28 2022-07-19 尤尼根公司 作为双核酶强效抑制剂的二芳基烷烃
US8168161B2 (en) * 2004-12-22 2012-05-01 Hill's Pet Nutrition, Inc. Method to promote oral health in companion animals
JP2006182662A (ja) * 2004-12-27 2006-07-13 Lion Corp 歯磨剤組成物
WO2006071659A1 (en) * 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
EP1942829A1 (de) 2005-11-04 2008-07-16 The Procter and Gamble Company Multifunktionsgerät für die mundpflege
US20070140990A1 (en) * 2005-12-21 2007-06-21 Nataly Fetissova Oral Compositions Comprising Propolis
EP2594278B1 (de) 2006-07-20 2016-09-07 Izun Pharmaceuticals Corporation Film, Pflaster oder feste klebendeformulierung beinhaltend Sambucus nigra, Centella asiatica und 1-alkypyridinium Salz zur Behandlung von Schleimhautgewebe.
US8142806B2 (en) * 2008-03-10 2012-03-27 University Of Louisville Research Foundation, Inc. Methods and compositions for controlled delivery of phytochemical agents
US8858995B2 (en) 2008-03-10 2014-10-14 University Of Louisville Research Foundation, Inc. Methods and compositions for controlled delivery of phytochemical agents
CA2730265C (en) 2008-07-21 2016-06-28 Unigen, Inc. Series of skin-whitening (lightening) compounds
WO2011106089A1 (en) * 2010-02-24 2011-09-01 Bisco, Inc. Benzalkonium chloride compositions for inhibiting the hydrolytic activity of endogenous matrix metalloproteinases in dental restorations
CN103492353A (zh) 2011-03-24 2014-01-01 尤尼根公司 用于制备二芳基丙烷的化合物和方法
US8731747B2 (en) 2011-04-28 2014-05-20 General Electric Company Communication systems and method for a rail vehicle or other powered system
US8620552B2 (en) 2011-06-13 2013-12-31 General Electric Company Data communication system and method for communicating data in a vehicle
US8798807B2 (en) 2011-06-13 2014-08-05 General Electric Company Data distribution system and method for distributing data in a vehicle
US8510026B2 (en) 2011-06-13 2013-08-13 General Electric Company Data conversion system and method for converting data that is distributed in a vehicle
CA2849910A1 (en) 2011-09-30 2013-04-04 Perio Sciences, Llc Antioxidant compositions for treatment of inflammation or oxidative damage
US20130274650A1 (en) * 2012-04-17 2013-10-17 Luitpold Pharmaceuticals, Inc. Stabilized ketorolac compositions
US20150210964A1 (en) 2014-01-24 2015-07-30 The Procter & Gamble Company Consumer Product Compositions
CN110024726B (zh) * 2019-04-03 2022-03-08 中国水产科学研究院长江水产研究所 天然产物在激活斑点叉尾鮰核受体ahr1和ahr2活性中的应用
WO2020210509A1 (en) * 2019-04-10 2020-10-15 Black Tulip Management, Inc. Oral rinse compositions for reducing pathogens underlying tooth decay, periodontitis and oral malodor
AU2020273162C1 (en) * 2019-04-10 2024-09-19 Black Tulip Management, Inc. Oral rinse compositions for reducing pathogens underlying and for treating periodontal disease and oral malodor in the canine
CN112494483B (zh) * 2020-11-13 2022-09-02 兰州大学 一种二硫杂环戊烯硫酮类化合物在抗菌方面的用途
CN115024355B (zh) * 2022-06-09 2023-06-09 宁波大学科学技术学院 对冷鲜肉保鲜的基于大蒜素的复合载体涂层的制备方法

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599228A (en) 1981-01-19 1986-07-08 Vipont Laboratories, Inc. Antimicrobial agent
US5531982A (en) * 1987-01-30 1996-07-02 Colgate Palmolive Company Antimicrobial oral composition
US5204089A (en) * 1989-08-30 1993-04-20 Mitsui Norin Co., Ltd. Method of preventing the formation or aggrevation of dental plaque and method for reducing cariogenesis
US5198220A (en) 1989-11-17 1993-03-30 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5464609A (en) 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
EP0449332B1 (de) * 1990-03-30 1995-08-02 Suntory Limited Glukosyltransferase-Inhibitoren sowie Verfahren zur Vorbeugung von Karies und anti-karöse Nahrungsmittel mittels dieser Inhibitoren
JPH0489428A (ja) 1990-07-30 1992-03-23 Kao Corp 多形核白血球活性化剤
US5147632A (en) * 1990-10-31 1992-09-15 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and chelating agent
US5356615A (en) 1991-01-30 1994-10-18 Colgate Palmolive Company Antiplaque oral compositions
GB9110721D0 (en) * 1991-05-17 1991-07-10 Unilever Plc Dentifrice compositions
AU665381B2 (en) 1992-01-23 1996-01-04 Morinaga Milk Industry Company Limited Antibacterial agent and treatment of article therewith
CN1075868A (zh) 1992-03-02 1993-09-08 池洁 一种保健牙签
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5431927A (en) * 1992-06-16 1995-07-11 Colgate-Palmolive Company Pet food product having oral care properties
US5830511A (en) 1992-06-25 1998-11-03 Bioxy Inc. Therapeutic, production and immunostimulatory uses of biocidal compositions
US6004587A (en) 1992-06-25 1999-12-21 Bioxy Inc. Therapeutic, production and immunostimulatory uses of biocidal compositions
JP3333584B2 (ja) * 1993-04-19 2002-10-15 三井農林株式会社 歯質の耐酸性強化組成物
JP3464807B2 (ja) 1993-04-27 2003-11-10 サンスター株式会社 歯磨用組成物
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
CN1103776A (zh) 1993-12-17 1995-06-21 王殿安 降压防栓保健药物牙膏
GB2290233B (en) 1994-05-21 1998-06-17 Medical Express Tooth-whitening compositions containing both chlorite and chlorate salts
CN1109742A (zh) 1994-09-22 1995-10-11 许我先 心、脑血管保健牙膏
US5578293A (en) 1994-12-06 1996-11-26 Colgate Palmolive Company Oral compositions containing stabilized stannous compounds having antiplaque and antitartar efficacy
US5639746A (en) 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
US5626838A (en) 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
US5672598A (en) 1995-03-21 1997-09-30 The Procter & Gamble Company Lactam-containing hydroxamic acids
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US6025326A (en) * 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
WO1997016159A1 (en) 1995-10-30 1997-05-09 Warner-Lambert Company Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils
EP0803243B1 (de) * 1996-04-24 2003-03-19 Pfizer Inc. Dentalwerkstoffe enthaltend Cyclodextrine und phenolische Verbindungen
CN1221338A (zh) * 1996-06-12 1999-06-30 普罗克特和甘保尔公司 H2－拮抗剂在制造治疗感冒的局部用组合物方面的用途
US5753217A (en) 1996-08-14 1998-05-19 William C. Christopfel Method of reducing oral malodor
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
BR9713465A (pt) 1996-08-28 2000-03-28 Procter & Gamble Inibidores metalotprotease de amina cìclica sibstituìda
TR199900429T2 (xx) 1996-08-28 1999-05-21 The Procter & Gamble Company Spirosiklik metaloproteaz inhibit�rleri.
DE69716934T2 (de) 1996-08-28 2003-07-31 The Procter & Gamble Company, Cincinnati 1,3-diheterozyklische metalloprotease inhibitoren
PL331854A1 (en) 1996-08-28 1999-08-16 Procter & Gamble Phosphinamides as inhibitors of metaloprotease matrix
AU731319B2 (en) 1996-08-28 2001-03-29 Procter & Gamble Company, The Heterocyclic metalloprotease inhibitors
BR9712792A (pt) 1996-08-28 1999-12-14 Procter & Gamble Inibidores de metaloprotease bidentada.
BR9712085A (pt) 1996-08-28 2000-10-24 Procter & Gamble Inibidores de metaloprotease heterocìclicos
CN1233956A (zh) 1996-10-22 1999-11-03 普罗克特和甘保尔公司 含有柠檬酸锌盐的经口组合物
AU722452B2 (en) 1996-10-22 2000-08-03 Procter & Gamble Company, The Oral compositions containing stannous gluconate
NZ335780A (en) 1996-10-23 2001-01-26 Univ New York State Res Found Compositions to control oral microbial oxidation-reduction (Eh) levels and treat gingivitis-periodontitis
US5906811A (en) * 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
WO1999006340A2 (en) 1997-07-31 1999-02-11 The Procter & Gamble Company Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
US5875798A (en) 1997-09-23 1999-03-02 Advanced Medical Instruments, Inc. Therapeutic toothpick for treating oral and systemic diseases
US5875799A (en) 1997-09-23 1999-03-02 Advanced Medical Instruments, Inc. Therapeutic dental floss for treating systemic diseases
CN1213534A (zh) 1997-10-06 1999-04-14 陈创 口体舒治疗保健系统牙膏
JPH11139947A (ja) 1997-11-11 1999-05-25 Sunstar Inc マトリックスメタロプロテアーゼ阻害剤含有口腔用組成物
US6228347B1 (en) * 1997-12-01 2001-05-08 Thione International, Inc. Antioxidant gel for gingival conditions
US6350438B1 (en) * 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
US6132702A (en) * 1998-02-27 2000-10-17 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
JP3763075B2 (ja) * 1998-04-24 2006-04-05 サンスター株式会社 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物
US8496914B2 (en) * 2005-12-13 2013-07-30 Richard Paul Bonfiglio Antibacterial oral rinse formulation for preventing coronary artery disease

Also Published As

Publication number Publication date
MXPA03000043A (es) 2003-10-15
WO2002002096A2 (en) 2002-01-10
PE20020102A1 (es) 2002-03-06
US8277782B2 (en) 2012-10-02
AU2001271544A1 (en) 2002-01-14
CA2415065C (en) 2009-09-15
JP4754155B2 (ja) 2011-08-24
EP1294367B1 (de) 2008-07-16
CA2415065A1 (en) 2002-01-10
WO2002002096A3 (en) 2002-09-12
US20060193790A1 (en) 2006-08-31
ES2309076T3 (es) 2008-12-16
EP1294367A2 (de) 2003-03-26
CN1536989A (zh) 2004-10-13
WO2002002096A8 (en) 2003-11-06
JP2004501966A (ja) 2004-01-22
DE60134854D1 (de) 2008-08-28

Similar Documents

Publication Publication Date Title
ATE401065T1 (de) Orale zubereitungen, die wirtsantwortmodulierenden wirkstoffe enthalten
ATE401089T1 (de) Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen
AR035482A1 (es) Uso de un compuesto de cianoquinolina para la manufactura de un medicamento para tratar o inhibir polipos colonicos
ATE378058T1 (de) Cannabis extrakten pharmazeutische zusammensetzung
AR012241A1 (es) Composicion de depuracion antimicrobiana mantenible y metodos para proporcionar efectividad residual y para tratar acne.
Greenstein Povidone‐iodine's effects and role in the management of periodontal diseases: a review
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
AR012172A2 (es) Composiciones farmaceuticas que comprenden analogos de lactacistina y uso de los mismos para la fabricacion de un medicamento
DE69033570D1 (de) Topische Zusammensetzungen, die LYCD und sonstige topische aktive Mittel enthalten
MX2007006212A (es) Medicamento oral para liberacion modificada de al menos un principio activo bajo forma multimicrocapsular.
ATE473749T1 (de) Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration
RS51154B (sr) Farmaceutske kompozicije koje sadrže niske koncentracije peroksida za lečenje i sprečavanje vaginalnih infekcija
DE50109650D1 (de) Topische behandlung bei der mastalgie
Eastham et al. Local drug delivery in the management of periodontal diseases part 2: Specific agents
KR20040087380A (ko) 구강세균에 대한 항균효과가 우수한 에센셜 오일 조성물
Shetty et al. Highlights on role of antibiotics in periodontics
Solomon et al. THE LOCAL ANTIBIOTHERAPY IN THE PERIODONTAL DISEASE TREATMENT. REVIEW.
CN1069516C (zh) 一种槟榔药物牙膏组合物
KR100417259B1 (ko) 트리암씨놀론 아세토나이드를 함유한 치은염, 구내염,치주염의 예방 및 치료용 구강 조성물
DOP2001000259A (es) Sistema de surfactantes para aumentar la captación de agente antibacteriano al tejido dental
YU75002A (sh) Lokalna antioksidantna vitaminska smeša za negu kože
Karthikeyan et al. Non-Antibacterial Implications of Tetracyclines in the Management of Periodontitis: An Update. J Immunodefic Disor 2: 1
BR0004104A (pt) Nova aplicação da ivermectina na acne rosácea
TH48587A (th) สารผสมบำรุงรักษาผิวหนัง ซึ่งมีสารแสดงฤทธิ์บำรุงรักษาผิวหนังรวมกัน
TH48994A (th) สารผสมบำรุงรักษาผิวหนัง ซึ่งมีสารแสดงฤทธิ์บำรุงรักษาผิวหนังรวมกัน

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties